MA42189A - Mã‰thodes de traitement des troubles du stockage lysosomal - Google Patents
Mã‰thodes de traitement des troubles du stockage lysosomalInfo
- Publication number
- MA42189A MA42189A MA042189A MA42189A MA42189A MA 42189 A MA42189 A MA 42189A MA 042189 A MA042189 A MA 042189A MA 42189 A MA42189 A MA 42189A MA 42189 A MA42189 A MA 42189A
- Authority
- MA
- Morocco
- Prior art keywords
- treatment
- lysosomal storage
- storage disorders
- disorders
- lysosomal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562147712P | 2015-04-15 | 2015-04-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA42189A true MA42189A (fr) | 2018-04-18 |
Family
ID=57126323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA042189A MA42189A (fr) | 2015-04-15 | 2016-04-14 | Mã‰thodes de traitement des troubles du stockage lysosomal |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20180092923A1 (fr) |
| EP (1) | EP3283477A1 (fr) |
| AU (1) | AU2016250190A1 (fr) |
| BR (1) | BR112017022032A2 (fr) |
| CA (1) | CA2982769A1 (fr) |
| MA (1) | MA42189A (fr) |
| MX (1) | MX2017013281A (fr) |
| TW (1) | TW201637655A (fr) |
| WO (1) | WO2016168420A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8809009B2 (en) | 2009-01-02 | 2014-08-19 | Biomarin Pharmaceutical Inc. | Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker |
| US9029530B2 (en) | 2009-01-02 | 2015-05-12 | Biomarin Pharmaceutical Inc. | Detection of oligosaccharides |
| US8232073B2 (en) * | 2009-01-02 | 2012-07-31 | Zacharon Pharmaceuticals, Inc. | Quantification of non-reducing end glycan residual compounds |
| AU2017388466B2 (en) * | 2016-12-29 | 2022-04-28 | Minoryx Therapeutics S.L. | Heteroaryl compounds and their use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006053112A1 (fr) * | 2004-11-10 | 2006-05-18 | Synta Pharmaceuticals Corp. | Procede destine a preparer des composes de pyrimidine trisubstitue |
| US9526707B2 (en) * | 2007-08-13 | 2016-12-27 | Howard L. Elford | Methods for treating or preventing neuroinflammation or autoimmune diseases |
| EP3004140A4 (fr) * | 2013-06-06 | 2017-01-25 | Angiochem Inc. | Composés enzymatiques ciblés et leurs utilisations |
-
2016
- 2016-04-14 AU AU2016250190A patent/AU2016250190A1/en not_active Abandoned
- 2016-04-14 MA MA042189A patent/MA42189A/fr unknown
- 2016-04-14 EP EP16780718.9A patent/EP3283477A1/fr not_active Withdrawn
- 2016-04-14 TW TW105111709A patent/TW201637655A/zh unknown
- 2016-04-14 BR BR112017022032A patent/BR112017022032A2/pt not_active Application Discontinuation
- 2016-04-14 CA CA2982769A patent/CA2982769A1/fr not_active Abandoned
- 2016-04-14 MX MX2017013281A patent/MX2017013281A/es unknown
- 2016-04-14 US US15/566,950 patent/US20180092923A1/en not_active Abandoned
- 2016-04-14 WO PCT/US2016/027473 patent/WO2016168420A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| MX2017013281A (es) | 2018-01-26 |
| US20180092923A1 (en) | 2018-04-05 |
| EP3283477A1 (fr) | 2018-02-21 |
| WO2016168420A1 (fr) | 2016-10-20 |
| TW201637655A (zh) | 2016-11-01 |
| AU2016250190A1 (en) | 2017-11-02 |
| BR112017022032A2 (pt) | 2018-07-03 |
| CA2982769A1 (fr) | 2016-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1249507A1 (zh) | 用於治療炎性障礙的新化合物及其藥物組合物 | |
| HK1219236A1 (zh) | 猝倒的治療 | |
| IL248538A0 (en) | Vector viruses unrelated to the treatment of lysosomal storage disorders | |
| MA39748A (fr) | Cenicriviroc pour le traitement de la fibrose | |
| GB201402070D0 (en) | Pharmaceutical compositions for the treatment of inflammatory disorders | |
| BR112016021629A2 (pt) | inibidores de c5a para o tratamento de pneumonia viral | |
| SI3116491T1 (sl) | Farmacevtski sestavki terapevtsko aktivnih spojin | |
| MA54925A (fr) | Compositions pour le traitement de troubles acido-basiques | |
| MA42999A (fr) | Polythérapie pour le traitement de malignités | |
| DK3158057T3 (da) | Stamcelleterapi ved endometriepatologier | |
| FR20C1044I2 (fr) | Triazines pour le traitement des infections protozoïques | |
| GB201401086D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders | |
| MA39927A (fr) | Inhibiteurs de glyt1 pour le traitement de troubles hématologiques | |
| HK1209032A1 (en) | Oxytocin receptor agonists for the treatment of cns diseases cns | |
| GB201413222D0 (en) | Treatment of liquid waste | |
| MA42189A (fr) | Mã‰thodes de traitement des troubles du stockage lysosomal | |
| FR3015285B1 (fr) | Formulation pour le traitement des cheveux | |
| MA42444A (fr) | Traitement du prurit | |
| PT3393517T (pt) | Ácido acetilsalicílico para utilização no tratamento de influenza moderada a grave | |
| ITUA20161679A1 (it) | Composizione per prevenire e trattare patologie neurodegenerative e disturbi cognitivi | |
| FI20146137A (fi) | Nanofibrilliselluloosan hydrogeelin lämpökäsittely | |
| MA41094A (fr) | Procédés de traitement de troubles rénaux | |
| MA41544A (fr) | Dosages de panobinostat pour le traitement du myélome multiple | |
| PL3164110T3 (pl) | Kompozycje farmaceutyczne do leczenia łuszczycy | |
| GB201514729D0 (en) | Treatment of haemorrhoids |